Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hunt Anthony | Director | Sep 10 '24 | Option Exercise | 33.87 | 10,000 | 338,700 | 162,031 | Sep 12 11:35 AM | Hunt Anthony | Director | Sep 10 '24 | Sale | 145.37 | 22,191 | 3,225,927 | 139,840 | Sep 12 11:35 AM | Hunt Anthony | Officer | Sep 10 '24 | Proposed Sale | 144.72 | 22,191 | 3,211,481 | | Sep 10 04:03 PM | KURIYEL RALF | Senior VP, R&D | Aug 02 '24 | Option Exercise | 86.10 | 175 | 15,067 | 12,463 | Aug 05 09:56 PM | KURIYEL RALF | Senior VP, R&D | Aug 02 '24 | Sale | 159.35 | 7,148 | 1,139,016 | 12,288 | Aug 05 09:56 PM | Ralf Kuriyel | Senior Vice President | Aug 02 '24 | Proposed Sale | 159.35 | 7,148 | 1,139,040 | | Aug 02 03:26 PM | KURIYEL RALF | Senior VP, R&D | Aug 01 '24 | Sale | 165.67 | 4,465 | 739,717 | 19,261 | Aug 01 08:47 PM | MUIR GLENN P | Director | Aug 01 '24 | Option Exercise | 36.29 | 5,000 | 181,450 | 13,283 | Aug 01 05:04 PM | Christine Gebski | Senior Vice President | Aug 01 '24 | Proposed Sale | 167.00 | 2,160 | 360,720 | | Aug 01 04:11 PM | Ralf Kuriyel | Senior Vice President | Aug 01 '24 | Proposed Sale | 165.67 | 4,465 | 739,705 | | Aug 01 04:07 PM | Madaus Martin D | Director | Jun 14 '24 | Buy | 124.94 | 1,615 | 201,776 | 4,613 | Jun 14 06:07 PM | BARTHELEMY NICOLAS | Director | Jun 14 '24 | Buy | 125.45 | 1,200 | 150,540 | 4,668 | Jun 14 05:42 PM | Hunt Anthony | Chief Executive Officer | Jun 14 '24 | Buy | 124.08 | 2,000 | 248,160 | 165,177 | Jun 14 05:41 PM | DAWES KAREN A | Director | Jun 14 '24 | Option Exercise | 67.71 | 2,953 | 199,948 | 88,170 | Jun 14 05:33 PM | Hunt Anthony | Chief Executive Officer | May 21 '24 | Sale | 168.26 | 20,072 | 3,377,283 | 163,177 | May 22 05:14 PM | KURIYEL RALF | Senior VP, R&D | Mar 11 '24 | Option Exercise | 86.10 | 1,271 | 109,433 | 27,777 | Mar 12 08:24 PM | KURIYEL RALF | Senior VP, R&D | Mar 11 '24 | Sale | 193.73 | 3,517 | 681,348 | 24,260 | Mar 12 08:24 PM | Hunt Anthony | Chief Executive Officer | Mar 08 '24 | Option Exercise | 16.55 | 1 | 17 | 201,956 | Mar 11 07:43 PM | Hunt Anthony | Chief Executive Officer | Mar 08 '24 | Sale | 197.44 | 16,707 | 3,298,632 | 185,249 | Mar 11 07:43 PM | DAWES KAREN A | Director | Feb 27 '24 | Option Exercise | 42.07 | 4,626 | 194,616 | 88,367 | Feb 28 09:56 PM | DAWES KAREN A | Director | Feb 27 '24 | Sale | 193.35 | 1,000 | 193,350 | 87,367 | Feb 28 09:56 PM | Bylund James | Chief Operating Officer | Feb 23 '24 | Option Exercise | 94.33 | 940 | 88,670 | 18,508 | Feb 26 08:38 PM | Bylund James | Chief Operating Officer | Feb 23 '24 | Sale | 198.08 | 4,373 | 866,204 | 14,135 | Feb 26 08:38 PM |
|